Univo Pharmaceuticals Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
UNVO
IL0010935588
Biotechnology & Medical Research
Sales 2019 | 0.82 3.03 65.29 | Sales 2020 | 33.68 123.95 2.67K | Capitalization | 75.1M 276M 5.95B |
---|---|---|---|---|---|
Net income 2019 | -11M -40.48M -872M | Net income 2020 | - 0 0 | EV / Sales 2019 | 35,543,010 x |
Net cash position 2019 | 22.82M 83.98M 1.81B | Net Debt 2020 | 4.12M 15.16M 326M | EV / Sales 2020 | 2,352,105 x |
P/E ratio 2019 * |
-
| P/E ratio 2020 |
-
| Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 59.28% |
Managers | Title | Age | Since |
---|---|---|---|
Golan Bitton
CEO | Chief Executive Officer | 48 | 03/04/93 |
Jonathan Eilat
IRC | Investor Relations Contact | - | - |
Noam Frakash
AUD | Comptroller/Controller/Auditor | 41 | 31/12/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chaim Hurvitz
CHM | Chairman | 63 | 14/07/19 |
Golan Bitton
CEO | Chief Executive Officer | 48 | 03/04/93 |
1st Jan change | Capi. | |
---|---|---|
+26.02% | 49.18B | |
+0.70% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+12.88% | 26.09B | |
-21.90% | 18.71B | |
+9.27% | 13.26B | |
+31.06% | 12.32B | |
-0.34% | 11.99B |